AD Genomics Manuscripts - Revision history

Bradley Monk at 03:22, 24 October 2018

2018-10-24T03:22:59Z

← Older revision		Revision as of 20:22, 23 October 2018
Line 6:		Line 6:

	{{Article\|Raghavan, et al. Mayeux, The Alzheimer's Disease Sequencing Project\|2018\|Annals of Clinical and Translational Neurology • [http://bradleymonk.com/w/images/b/b8/Raghavan2018.pdf PDF]\|30009200\|Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease.}} <br>		{{Article\|Raghavan, et al. Mayeux, The Alzheimer's Disease Sequencing Project\|2018\|Annals of Clinical and Translational Neurology • [http://bradleymonk.com/w/images/b/b8/Raghavan2018.pdf PDF]\|30009200\|Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease.}} <br>

			Note: The ADSP was an author on this paper.

	<big>Summary</big>		<big>Summary</big>

	~~ADSP was the last author on this paper.~~ Using the ADSP dataset, the goal was to identify the frequency and impact of rare and ultra‐rare variants in Alzheimer's disease, using whole‐exome sequencing in 20,197 individuals.		Using the ADSP dataset, the goal was to identify the frequency and impact of rare and ultra‐rare variants in Alzheimer's disease, using whole‐exome sequencing in 20,197 individuals.

	They identified 19 cases carrying extremely rare {{Gene\|SORL1}} loss‐of‐function variants among a collection of 6,965 cases and a single loss‐of‐function variant among 13,252 controls (P = 2e10−8; OR: 36.2 [95% CI: 5.8–1493.0]). Age‐at‐onset was 7 years earlier for patients with SORL1 qualifying variant compared with noncarriers.		They identified 19 cases carrying extremely rare {{Gene\|SORL1}} loss‐of‐function variants among a collection of 6,965 cases and a single loss‐of‐function variant among 13,252 controls (P = 2e10−8; OR: 36.2 [95% CI: 5.8–1493.0]). Age‐at‐onset was 7 years earlier for patients with SORL1 qualifying variant compared with noncarriers.

	No other gene attained a study‐wide level of statistical significance, but multiple top‐ranked genes, including GRID2IP,WDR76 and GRN, were among candidates for follow‐up studies.		No other gene attained a study‐wide level of statistical significance, but multiple top‐ranked genes, including {{Gene\|GRID2IP}}, {{Gene\|WDR76}} and {{Gene\|GRN}}, were among candidates for follow‐up studies.

Bradley Monk at 03:14, 24 October 2018

2018-10-24T03:14:43Z

← Older revision		Revision as of 20:14, 23 October 2018
Line 11:		Line 11:
	ADSP was the last author on this paper. Using the ADSP dataset, the goal was to identify the frequency and impact of rare and ultra‐rare variants in Alzheimer's disease, using whole‐exome sequencing in 20,197 individuals.		ADSP was the last author on this paper. Using the ADSP dataset, the goal was to identify the frequency and impact of rare and ultra‐rare variants in Alzheimer's disease, using whole‐exome sequencing in 20,197 individuals.

	They identified 19 cases carrying extremely rare SORL1 loss‐of‐function variants among a collection of 6,965 cases and a single loss‐of‐function variant among 13,252 controls (P = 2e10−8; OR: 36.2 [95% CI: 5.8–1493.0]). Age‐at‐onset was 7 years earlier for patients with SORL1 qualifying variant compared with noncarriers.		They identified 19 cases carrying extremely rare {{Gene\|SORL1}} loss‐of‐function variants among a collection of 6,965 cases and a single loss‐of‐function variant among 13,252 controls (P = 2e10−8; OR: 36.2 [95% CI: 5.8–1493.0]). Age‐at‐onset was 7 years earlier for patients with SORL1 qualifying variant compared with noncarriers.

	No other gene attained a study‐wide level of statistical significance, but multiple top‐ranked genes, including GRID2IP,WDR76 and GRN, were among candidates for follow‐up studies.		No other gene attained a study‐wide level of statistical significance, but multiple top‐ranked genes, including GRID2IP,WDR76 and GRN, were among candidates for follow‐up studies.

Bradley Monk at 23:30, 22 October 2018

2018-10-22T23:30:52Z

← Older revision		Revision as of 16:30, 22 October 2018
Line 10:		Line 10:

	ADSP was the last author on this paper. Using the ADSP dataset, the goal was to identify the frequency and impact of rare and ultra‐rare variants in Alzheimer's disease, using whole‐exome sequencing in 20,197 individuals.		ADSP was the last author on this paper. Using the ADSP dataset, the goal was to identify the frequency and impact of rare and ultra‐rare variants in Alzheimer's disease, using whole‐exome sequencing in 20,197 individuals.

			They identified 19 cases carrying extremely rare SORL1 loss‐of‐function variants among a collection of 6,965 cases and a single loss‐of‐function variant among 13,252 controls (P = 2e10−8; OR: 36.2 [95% CI: 5.8–1493.0]). Age‐at‐onset was 7 years earlier for patients with SORL1 qualifying variant compared with noncarriers.

			No other gene attained a study‐wide level of statistical significance, but multiple top‐ranked genes, including GRID2IP,WDR76 and GRN, were among candidates for follow‐up studies.

Bradley Monk at 23:13, 22 October 2018

2018-10-22T23:13:20Z

← Older revision		Revision as of 16:13, 22 October 2018
Line 1:		Line 1:
	Articles on or related to the Alzheimer's Disease Sequencing Project (ADSP)		===Articles on or related to the Alzheimer's Disease Sequencing Project (ADSP)===

	~~==Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease==~~		<br><br><br>

	{{Article\|Raghavan, et al. Mayeux, The Alzheimer's Disease Sequencing Project\|2018\|Annals of Clinical and Translational Neurology • [http://bradleymonk.com/w/images/b/b8/Raghavan2018.pdf PDF]\|30009200\|Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease.}}		====Raghavan 2008====

			{{Article\|Raghavan, et al. Mayeux, The Alzheimer's Disease Sequencing Project\|2018\|Annals of Clinical and Translational Neurology • [http://bradleymonk.com/w/images/b/b8/Raghavan2018.pdf PDF]\|30009200\|Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease.}} <br>

			<big>Summary</big>

			ADSP was the last author on this paper. Using the ADSP dataset, the goal was to identify the frequency and impact of rare and ultra‐rare variants in Alzheimer's disease, using whole‐exome sequencing in 20,197 individuals.

Bradley Monk at 23:08, 22 October 2018

2018-10-22T23:08:21Z

← Older revision		Revision as of 16:08, 22 October 2018
Line 1:		Line 1:
			Articles on or related to the Alzheimer's Disease Sequencing Project (ADSP)

	Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease.		==Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease==

	Raghavan, et al. Mayeux, The Alzheimer's Disease Sequencing Project		{{Article\|Raghavan, et al. Mayeux, The Alzheimer's Disease Sequencing Project\|2018\|Annals of Clinical and Translational Neurology • [http://bradleymonk.com/w/images/b/b8/Raghavan2018.pdf PDF]\|30009200\|Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease.}}

Bradley Monk: Created page with " Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease. Raghavan, et al. Mayeux, The Alzheimer's Disease Sequencing Project"

2018-10-22T23:03:06Z

Created page with " Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease. Raghavan, et al. Mayeux, The Alzheimer's Disease Sequencing Project"

New page

Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease.

Raghavan, et al. Mayeux, The Alzheimer's Disease Sequencing Project